Menu
Recruiting NCT03252795

Uterus Transplantation From a Multi-organ Donor

No phase Interventional Infertility, Female Mayer Rokitansky Kuster Hauser Syndrome

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: uterus transplantation.
Who it may be relevant to
Registry conditions: Infertility, Female, Mayer Rokitansky Kuster Hauser Syndrome. Basic parameters: 18 years — 38 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Belgium
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Uterus Transplantation From a Multi-organ Donor: A Prospective Trial

Overview

Uterus transplantation: screening, in vitro fertilization \[IVF\] treatment to be able to freeze embryos, uterus transplantation, pregnancy and afterwards removal of the uterus.

Interventions

  • Procedure uterus transplantation
    transplantation of a uterus from a deceased donor

Primary outcome measures

  • Survival of the uterus 1 year after transplantation [Time frame: 1 year after uterus transplantation]
  • Complications after uterus transplantation [Time frame: As long as the uterus remains in situ (the uterus will be removed within one year after delivery)]
  • Ongoing pregnancy rate [Time frame: 4 weeks after embryo transfer]
  • Take home baby rate [Time frame: 9 months after embryo transfer]

Eligibility criteria

Inclusion criteria

  • Female with Maier-Rokitansky-Kuster-Hauser syndrome
  • Mucosal neovagina of at least 7 cm
  • In a stable relationship for at least 1 year
  • Child wish
  • Good renal function (and presence of both kidneys)
  • Psychologically stable and compliant
  • At least 8 frozen embryos after IVF/intracytoplasmic sperm injection \[ICSI\]
  • Living in Belgium and a good health insurance
  • Willing and able to provide informed consent

Exclusion criteria

  • Major pelvic surgery
  • Major chronic illnesses
  • Other risk factors or malignancies
  • BMI > 30

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Belgium · 1 center
  • Ghent University Hospital - Women's Clinic — Ghent

Identifiers

NCT: NCT03252795 · EC/2016/0731

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗